Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 7
2008 6
2009 9
2010 98
2011 161
2012 194
2013 260
2014 1030
2015 3539
2016 6855
2017 10350
2018 3195
2019 762
2020 434
2021 291
2022 86
Text availability
Article attribute
Article type
Publication date

Search Results

26,382 results
Results by year
Filters applied: . Clear all
Page 1
HPV: Immunology lessons from an ancient oncotarget.
Krishna S, Anderson KS. Krishna S, et al. Oncotarget. 2019 Feb 12;10(13):1269-1270. doi: 10.18632/oncotarget.26606. eCollection 2019 Feb 12. Oncotarget. 2019. PMID: 30863487 Free PMC article. No abstract available.
Beyond RAS and BRAF: HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer.
Guarini C, Grassi T, Pezzicoli G, Porta C. Guarini C, et al. Int J Mol Sci. 2021 Jun 24;22(13):6813. doi: 10.3390/ijms22136813. Int J Mol Sci. 2021. PMID: 34202896 Free PMC article. Review.
HER2 alterations, including amplification and somatic mutations, have also been detected in a small but not negligible subset of patients affected by advanced colorectal cancer (aCRC). However, to date, there are no available oncotargets in this malignancy beyond RAS and B …
HER2 alterations, including amplification and somatic mutations, have also been detected in a small but not negligible subset of patients af …
Librarians against scientists: Oncotarget's lesson.
Blagosklonny MV. Blagosklonny MV. Oncotarget. 2018 Jan 19;9(5):5515-5516. doi: 10.18632/oncotarget.24272. eCollection 2018 Jan 19. Oncotarget. 2018. PMID: 29464014 Free PMC article. No abstract available.
Targeting Trop-2 in solid tumors: future prospects.
Zaman S, Jadid H, Denson AC, Gray JE. Zaman S, et al. Onco Targets Ther. 2019 Mar 1;12:1781-1790. doi: 10.2147/OTT.S162447. eCollection 2019. Onco Targets Ther. 2019. PMID: 30881031 Free PMC article. Review.
DNp73: oncotarget in invasion and metastasis.
Pützer BM. Pützer BM. Oncotarget. 2014 Jan 15;5(1):3-4. doi: 10.18632/oncotarget.1746. Oncotarget. 2014. PMID: 24398448 Free PMC article. No abstract available.
Hexokinase 2 as oncotarget.
Patra KC, Hay N. Patra KC, et al. Oncotarget. 2013 Nov;4(11):1862-3. doi: 10.18632/oncotarget.1563. Oncotarget. 2013. PMID: 24196563 Free PMC article. No abstract available.
Correction: Librarians against scientists: Oncotarget's lesson.
Blagosklonny MV. Blagosklonny MV. Oncotarget. 2018 Mar 13;9(19):15167. doi: 10.18632/oncotarget.24692. eCollection 2018 Mar 13. Oncotarget. 2018. PMID: 29601072 Free PMC article.
[This corrects the article DOI: 10.18632/oncotarget.24272.]....
[This corrects the article DOI: 10.18632/oncotarget.24272.]....
Structural homologies between phenformin, lipitor and gleevec aim the same metabolic oncotarget in leukemia and melanoma.
Somlyai G, Collins TQ, Meuillet EJ, Hitendra P, D'Agostino DP, Boros LG. Somlyai G, et al. Oncotarget. 2017 Jul 25;8(30):50187-50192. doi: 10.18632/oncotarget.16238. Oncotarget. 2017. PMID: 28418852 Free PMC article. Review.
The alternative perspective for Gleevec's mode of action may turn oncotargets towards metabolic channel reaction architectures in leukemia and melanoma, as well as in other cancers....
The alternative perspective for Gleevec's mode of action may turn oncotargets towards metabolic channel reaction architectures in leu …
Galectin-1 as an oncotarget in gliomas and melanomas.
Lefranc F, Mathieu V, Kiss R. Lefranc F, et al. Oncotarget. 2011 Dec;2(12):892-3. doi: 10.18632/oncotarget.408. Oncotarget. 2011. PMID: 22248884 Free PMC article. No abstract available.
26,382 results
You have reached the last available page of results. Please see the User Guide for more information.